Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-15628.08	-556.00	-3.54
Graham Fair Price	-94.05	0.44	7.36
PEG	638233.21	-1.21	< 0.005
Price/Book	-21.03	0.52	0.66
Price/Cash Flow	-22585.39	-480.64	-2.12
Prices/Earnings	-22651.20	-120.51	-0.53
Price/Sales	172.49	274.37	100.69
Price/FCF	-22585.39	-480.64	-2.12
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	89.57	0.33	-0.17
Operating Margin	93.45	-1.18	-17.98
ROA	99.65	< 0.005	-0.23
ROE	-0.31	< 0.005	99.65
ROIC	-0.15	< 0.005	99.37
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	-0.02	67.00
Dividends QOQ	-0.03	-0.02	47.13
EBIT QOQ	-9.54	0.98	-89.71
EPS QOQ	-27.96	1.00	-96.44
FCF QOQ	-28.66	1.00	-96.52
Revenue QOQ	1.73	-0.71	-58.79
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	33.44	201.04	501.13
Days Sales Outstanding (DSO)	114.37	183.39	60.35
Inventory Turnover	2.69	0.45	-83.36
Debt/Capitalization	0.09	0.09	-0.43
Quick Ratio	0.11	0.04	-61.43
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	2.79	2.82	1.03
Cash	< 0.005	< 0.005	-66.27
Capex	0.00	< 0.005	-100.00
Free Cash Flow	-0.86	< 0.005	99.65
Revenue	0.02	< 0.005	-70.72
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.19	0.12	-35.63
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-0.44	-85.27	-19365.49
Naive Interpretation	Member

06 - Financial Health · Bad

Rating